CSPC Pharmaceutical Group Limited CSPCY
3.97 USD -0.03 (-0.75%)
Regular-session close
4.00 Day range 4.00
3.26 52-week range 5.46
- YTD
- -7.89%
- 1 year
- -2.93%
News
reuters.com AstraZeneca signs CSPC China deal for experimental kidney disease drugs AstraZeneca has entered into a deal worth up to $1.77 billion with CSPC Pharmaceutical Group to discover and develop experimental medicines with the potential to treat kidney diseases, the Chinese…
proactiveinvestors.co.uk AstraZeneca obesity tie-up with CSPC seen as shrewd move AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) licensing deal on Friday signals a plausible effort by the FTSE 100 group to grab a piece of a booming market for obesity treatments, analysts said, with still…
defenseworld.net CSPC Pharmaceutical Group (OTCMKTS:CSPCY) Shares Down 0.5% – Here’s What Happened CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY - Get Free Report)'s share price traded down 0.5% during trading on Thursday. The company traded as low as C$3.88 and last traded at C$3.91. 35,649…
